Mpox secrets revealed: new study tracks virus clearance and transmission

NCT ID NCT07267390

Completed Knowledge-focused Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 550 people with mpox to see how long the virus stays in the body and how it spreads to close contacts. Researchers measured viral levels in skin lesions, throat swabs, and blood over time. The goal is to provide better guidance on when it's safe to stop isolating and how to prevent further spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide clear guidelines on how long people with mpox should isolate and help public health officials better target contact tracing and vaccination efforts.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly lead to new therapies. Results may be specific to the outbreak context and may not apply to future variants or different populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MPOX (MONKEYPOX) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

monkeypox

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MPOX (MONKEYPOX)

Contacts and locations

Locations

Univeristy of Kinshasa

Kinshasa, Democratic Republic of the Congo

More trials for these conditions

Other studies related to the condition(s) this trial covers.